Affiliation:
1. From the Department of Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, FL
2. Departments of Medicine and Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.
Abstract
One of the leading causes of maternal death in the United States is venous thromboembolism (VTE), which is influenced by acquired, genetic, and environmental factors. Pregnancy-associated physiological changes that exhibit the characteristics of Virchow’s triad: reduced fibrinolysis, increased coagulation factors, trauma, and venous stasis all raise the risk of VTE. Furthermore, multiple gestations, advanced maternal age, cesarean delivery, and obesity are all pregnancy-associated risk factors that also increase the risk of VTE. Management of VTE during pregnancy can be challenging due to the risks and benefits of anticoagulant therapy and potential hazard for both the fetus and the mother. In this review, we discuss the prevalence, pathogenesis, predisposing factors, and therapeutic options such as systemic thrombolysis, mechanical thrombectomy, and catheter-directed thrombolysis.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference84 articles.
1. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.;James;Am J Obstet Gynecol,2006
2. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy.;Gherman;Obstet Gynecol,1999
3. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database.;Simpson;BJOG,2001
4. Thrombosis during pregnancy and the postpartum period.;James;Am J Obstet Gynecol,2005
5. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation.;Ray;Obstet Gynecol Surv,1999